U.S. Auto Components Stock News

In early April 2026, Skyworks Solutions proposed amending its charter to eliminate supermajority voting requirements for major transactions, while also opposing a shareholder proposal from Green Century Funds seeking an expanded report on greenhouse gas emissions reduction efforts ahead of the May 13, 2026 annual meeting. This combination of governance reform and pushback on environmental reporting highlights an important tension between management control and investor demands for stronger...

Why Gap Stock Is Back On Watch For Retail Investors Gap (GAP) has recently drawn renewed attention after a period of mixed share performance, with positive moves over the past month contrasting with weaker returns over the past 3 months. See our latest analysis for Gap. Gap’s recent 11.29% 1 month share price return contrasts with a 10.52% 3 month share price decline, while its 1 year total shareholder return of 28.94% highlights a shift in momentum following earlier volatility. If Gap’s...

AeroVironment (NasdaqGS:AVAV) has secured a new multi-year US Air Force contract for its UES division. The program focuses on transitioning advanced sensor, diagnostic, and biotechnology tools from research labs into operational use. The goal is to improve warfighter health, resilience, and survivability through fielded health and performance technology. For investors who know AeroVironment mainly for unmanned systems and intelligence, surveillance, and reconnaissance, this contract...

RTX (NYSE:RTX) has been awarded a US$50b multi year Department of Defense contract for Patriot missile defense systems. The agreement covers production and long term sustainment of Patriot systems used by the US and allied militaries. This contract takes RTX's total backlog to a record US$268b. For investors watching RTX at a current share price of US$203.48, this contract follows very strong longer term returns, with the stock up 61.1% over the past year and 191.9% over five years. The new...

Waystar Holding stock performance snapshot Waystar Holding (WAY) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year. See our latest analysis for Waystar Holding. With the latest share price at $22.65, the stock has faced continued selling pressure, with a 30 day share price return of 12.48% and a 1 year total shareholder return of 39.63%. This suggests recent momentum is fading as investors...

In Q4 2025, Federal Signal reported a strong performance boost, with orders rising to US$647 million and both Environmental Solutions and Safety & Security Systems contributing meaningfully to growth, while also issuing an optimistic outlook for fiscal 2026 despite ongoing supply chain and integration challenges. This combination of robust segment demand and a growing order book highlights how Federal Signal’s mix of environmental and safety solutions is underpinning confidence in its...

Wondering if PBF Energy at around US$43 is still offering value after a strong run, or if most of the opportunity has already been priced in. The stock has been volatile recently, with a 6.6% decline over the last 7 days, a 12.9% gain over 30 days, a 50.8% return year to date, and a 172.6% return over the past year. Recent news around refining margins, fuel demand trends, or sector wide sentiment has been helping shape expectations for refiners like PBF Energy. These headlines often...

GRAIL is integrating its Galleri multi cancer early detection blood test into Epic's electronic health record system across U.S. health systems. The integration will allow clinicians to order Galleri and review results within existing Epic workflows. The move is intended to broaden access to the test and streamline patient management at scale. GRAIL, listed as NasdaqGS:GRAL, comes into this Epic integration with a share price of $50.77 and a 1 year return of 103.9%. Year to date, the stock...

Conference spotlight and recent stock pressure NuScale Power (SMR) heads into its World Chemical Forum 2026 presentation on March 26 after a 15.6% share price drop in March tied to disappointing fourth quarter 2025 financial results and softer sentiment. With project delays and the path to commercial operations under scrutiny, this conference appearance and the upcoming first quarter 2026 results call are likely to shape how investors think about NuScale Power's small modular reactor business...

Wondering if Tyson Foods at around US$64.65 is offering fair value or a potential mispricing? This article walks through what the current data actually says about the stock. Over the last week the share price return is 0.5%, over 30 days it is 5.4%, year to date it is 11.4% and over the past year it is 12.0%. Together, these figures give you a recent snapshot of how the market has been pricing the company. Recent attention on Tyson Foods has focused on its share price performance and how...

Recently, analysts highlighted that Qualcomm faces softer near-term fundamentals, with earnings estimates revised lower amid continued pressure in its core smartphone-chip business and license uncertainty with Apple. At the same time, Qualcomm’s expanding automotive and edge AI activities, including multi-year deals with Volkswagen and Toyota and new industrial and healthcare collaborations, underline how fast its revenue mix is shifting beyond handsets. Next, we’ll examine how these weaker...

Why Enovix Is Back on Radar After AR Partnership Buzz and Earnings Beat Enovix (ENVX) drew fresh attention after reports of a potential Meta-Bounds partnership related to AR glasses battery life and quarterly results that surpassed revenue and adjusted loss expectations. For you as an investor, the combination of partnership speculation, better-than-expected financials, and ongoing operational questions creates a stock story that is being reassessed rather than simply celebrated. See our...

Wondering if Altria Group at around US$66.80 is still offering value, or if most of the return is already behind it? This article walks through what the current price might be implying. The share price sits at US$66.80 after a 2.0% move over the last 7 days, with a small 0.4% decline over 30 days. The year-to-date return is 16.6%, the 1-year return is 26.9%, and the 3- and 5-year returns are 88.4% and 91.9% respectively. Recent coverage has focused mainly on Altria Group's role in the US...

Nectar Social and Reddit recently announced a data partnership that gives Nectar access to Reddit’s Data API, integrating conversations from over 100,000 communities into Nectar’s platform alongside Instagram, TikTok, Facebook, YouTube, X, and other social channels. This tie-up turns Reddit’s human, interest-based discussions into SKU-level insights for brands, potentially deepening Reddit’s role in social commerce, product feedback, and real-time sentiment analysis. We’ll now examine how...

Context for recent Flex moves Flex (FLEX) has attracted fresh attention after recent share price gains, with the stock up over 19% in the past month and about 21% in the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for Flex. Flex’s recent 1 day share price return of 7.30% and 1 month share price return of 19.34% sit on top of a very large 5 year total shareholder return of 456.21%. This suggests momentum has been building rather than fading around the...

Solaris Energy Infrastructure (SEI) is back on traders’ screens after fresh coverage and rating changes from major banks highlighted its growing power generation capacity and possible exposure to rising AI-related electricity demand. See our latest analysis for Solaris Energy Infrastructure. The fresh bank coverage appears to be landing on a stock where momentum is already strong, with a 23.4% 1 month share price return and very large 1 year and 3 year total shareholder returns, suggesting...

United Therapeutics recently reported that its Phase 3 TETON-1 trial showed nebulized Tyvaso improved lung function in idiopathic pulmonary fibrosis patients, and the FDA granted Regenerative Medicine Advanced Therapy designation to its investigational miroliverELAP external liver support device. These twin advances, spanning both respiratory disease and bioengineered organ support, underscore how United Therapeutics is pushing into high-need areas using differentiated regenerative and...

Catalyst Pharmaceuticals has secured extended U.S. patent exclusivity for its rare disease drug Firdapse until 2035 and launched the muscle disorder therapy Agamree, adding another commercial product to its portfolio. This combination of longer exclusivity for a core neuromuscular asset and the addition of a new revenue source could materially reshape the company’s rare disease focus and product concentration profile. We’ll examine how Firdapse’s extended exclusivity to 2035 could influence...

In late March and early April 2026, Mint Mobile announced a $45/month “Unf*! Your Bills” annual bundle of 5G Home MINTernet and unlimited premium wireless, while T-Mobile expanded 5G-powered partnerships with Serve Robotics, McGraw Hill and Motorola Solutions and recorded a Board resignation from Abdurazak Mudesir. Together, the low-cost Mint bundle and 5G collaborations highlight how T-Mobile is pushing deeper into home broadband, education connectivity, public safety and real-time AI...

MSCI (MSCI) has agreed to acquire PM Insights, a private markets data and analytics provider, giving investors a fresh development to assess in relation to the company’s push into institutional-grade tools for private asset investing. See our latest analysis for MSCI. Beyond the PM Insights deal, MSCI has also announced a new index partnership with Syntax Data and upcoming 2026 earnings calls. Its 1-year total shareholder return of 2.75% and 5-year total shareholder return of 28.44% indicate...

In March 2026, Associated Wholesale Grocers and Symbotic announced a plan to deploy Symbotic’s next-generation warehouse automation across 114,000 square feet of AWG’s Gulf Coast Division Support Center in Pearl River, Louisiana, targeting nearly 19 million automated dry-grocery cases annually from a currently manual operation handling over 22 million cases. This agreement highlights how Symbotic’s high-density, end-to-end automation is being used to address labor constraints, cost...

Maximus, Inc. recently declared a quarterly cash dividend of US$0.33 per share, payable on June 1, 2026, to shareholders of record as of May 15, 2026, while also raising its full-year adjusted earnings per share outlook and narrowing its revenue forecast following a divestiture. The dividend increase, upgraded EPS guidance, and extensive share repurchases highlight management’s emphasis on returning capital to investors while signaling confidence in the company’s ability to generate...

Stoke Therapeutics recently expanded its Board of Directors to ten members and appointed G. Clare Kahn, Ph.D., as a Class I director and chair of the Research and Development Committee, adding deep regulatory and drug development expertise as the company advances its Phase 3 program for zorevunersen in Dravet syndrome. By placing an industry veteran with extensive rare disease and regulatory experience at the center of board-level R&D oversight, Stoke is signaling a sharpened focus on...

In the past quarter, Columbia Sportswear reported revenue, EPS and EBITDA above analyst expectations and raised its full-year guidance under its ACCELERATE Growth Strategy. Management pointed to stronger-than-anticipated U.S. demand alongside continued international expansion as key drivers, even as the wider sector faces ongoing challenges. Next, we’ll examine how this guidance increase and stronger U.S. demand may influence Columbia Sportswear’s existing investment narrative and...